Neonc Technologies Holdings (NTHI) Assets Average (2025 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Assets Average of $3.1 million for Q1 2026, down 48.11% year-over-year from $5.9 million in Q1 2025, and down 10.9% quarter-over-quarter from $3.5 million in Q4 2025.
Neonc Technologies Holdings (NTHI) Assets Average (2025 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Assets Average for 2 consecutive years, with $3.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average fell 48.11% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (down 48.11% YoY), while the FY2025 annual figure was $3.1 million, changed N/A from the prior year.
- Assets Average declined to $3.1 million in Q1 2026 per NTHI's latest filing, from $3.5 million in the prior quarter.
- Across five years, Assets Average topped out at $5.9 million in Q1 2025 and bottomed at $3.1 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | 4.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.28 Mn |
| Mar 31, 2026 | 3.08 Mn |
| Dec 31, 2025 | 3.45 Mn |
| Sep 30, 2025 | 3.54 Mn |
| Jun 30, 2025 | 5.71 Mn |
| Mar 31, 2025 | 5.93 Mn |